Journals / Dicle Tıp Dergisi / 2021 / Cilt: 48 - Sayı: 2

The Colposcopic Histopathology Results in Major Cytological Abnormalities: 5 Years Experience in a Tertiary Center

Major Sitolojik Anormalliklerde Kolposkopik Histopatoloji Sonuçlarımız: Tersiyer bir Merkezde 5 Yıllık Deneyim

Pages
282–291
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Reflex HPV test may be useful in those with negative colposcopic histopathology results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare the rates of high grade cervical preinvasive lesions and cancer (HSIL+) diagnosed as a result of colposcopic interventions in women whose cytology results are AGC, ASCH and HSIL, depending on the condition of Human Papillomavirus (HPV) and age.
📊
Key Findings & Data:Method: 387 patients who had AGC, ASCH and HSIL, who applied to the Colposcopy unit of the Health Sciences University TCSB Etlik Zübeyde Hanım Gynecology Training Research Hospital between January 2015 and December 2019, and who had colposcopy for the first time, were included in the study.
💡
Conclusion & Impact:Reflex HPV test may be useful in those with negative colposcopic histopathology results.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To compare the rates of high grade cervical preinvasive lesions and cancer (HSIL+) diagnosed as a result of colposcopic interventions in women whose cytology results are AGC, ASCH and HSIL, depending on the condition of Human Papillomavirus (HPV) and age. Method: 387 patients who had AGC, ASCH and HSIL, who applied to the Colposcopy unit of the Health Sciences University TCSB Etlik Zübeyde Hanım Gynecology Training Research Hospital between January 2015 and December 2019, and who had colposcopy for the first time, were included in the study. The patients included in the study were compared in terms of histopathological HSIL and cancer results by stratifying HPV status and age groups: under 30, 30-39, 40-49 and 50 and above. Results: HSIL ratios in AGC, ASCH and HSIL cytology groups were 14.7%, 40.8% and 60.4%, respectively; cancer rates were found to be 9.1%, 3.2% and 12.4%, respectively. The rates of HPV16 and HPV18 types in AGC, ASCH and HSIL groups are 56.2%, 84.4% and 88.9%, respectively. According to HPV status, HSIL+ rates are 50%, 54.8% and 81.5% in HPV16/18 positive AGC, ASCH and HSIL cytology groups. Invasive cancer was not detected in all three groups under the age of 30, and in groups 30-39, 40-49 and 50 and above, it was 5.4%, 8.1% and 9.6%, respectively. Conclusions: In the AGC, ASCH and HSIL cytology groups, HSIL + rates are high as in the literature, and colposcopy is required immediately. The most common HPV type in all three groups is HPV 16. Reflex HPV test may be useful in those with negative colposcopic histopathology results.

Özet

Amaç: Sitoloji sonucu AGC, ASCH ve HSIL olan kadınlardaki kolposkopik girişimler sonucu tanı konulan yüksek dereceli servikal preinvaziv lezyon ve kanser(HSIL+) oranlarını Human Papillomavirus (HPV) durumu ve yaşa bağlı olarak karşılaştırmaktı. Yöntemler: Ocak 2015-Aralık 2019 tarihleri arasında hastanemiz kolposkopi ünitesine başvuran sitoloji sonucu AGC, ASCH ve HSIL olan ve ilk kez kolposkopi yapılan 387 hasta çalışmaya alındı. Çalışmaya alınan hastalar histopatolojik HSIL ve kanser sonuçları açısından HPV durumu ve yaş grupları: 30 altı, 30-39, 40-49 ve 50 ve üstü şeklinde tabakalandırılarak karşılaştırıldı. Bulgular: AGC, ASCH ve HSIL sitoloji gruplarında HSIL oranları sırasıyla %14,7, %40,8 ve %60,4’tür; kanser oranları ise sırasıyla %9,1, %3,2 ve %12,4 olarak bulunmuştur. HPV16 ve HPV18 tiplerinin AGC, ASCH ve HSIL gruplarındaki oranları sırasıyla %56,2, %84,4 ve %88,9’dur. HPV durumuna göre HPV16/18 pozitif AGC, ASCH ve HSIL sitoloji gruplarında HSIL+ oranları sırasıyla %50, %54.8 ve %81,5’dir. Sitoloji gruplarındaki invaziv kanserler yaşa göre değerlendirildiğinde; 30 yaş altında her üç grupta da invaziv kanser saptanmamış olup 30-39, 40-49 ve 50 ve üstü gruplarda sırasıyla %5,4, %8,1 ve %9,6’dır. Sonuçlar: AGC, ASCH ve HSIL sitoloji gruplarında HSIL+ oranları literatürde olduğu gibi yüksek olup hemen kolposkopi gereklidir. Her üç grupta da en sık görülen HPV tipi HPV 16’dır. Kolposkopik histopatoloji sonuçları negatif olanlarda refleks HPV testi yararlı olabilir.

🔖

Cite This Article

ÜNLÜBİLGİN, E., KOÇ, S. (2021). The Colposcopic Histopathology Results in Major Cytological Abnormalities: 5 Years Experience in a Tertiary Center. Dicle Tıp Dergisi, Cilt: 48 - Sayı: 2, 282–291. https://ajindex.com/articles/348768

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bray F, Ferlay J, Soerjomataram I, et al. GlobalCancer Statistics 2018: GLOBOCAN Estimates ofIncidence and Mortality Worldwide for 36 Cancersin 185 Countries. CA Cancer J Clin. 2018
  2. Flanagan MB. Primary high-risk humanpapillomavirus testing for cervical cancer screeningin the United States: is it time? Arch Pathol Lab Med.2018
  3. Solomon D, Davey D, Kurman R et al. The 2001Bethesda System: terminology for reporting resultsof cervical cytology. JAMA. 2002
  4. Perkins RB, Guido RS, Castle PE et al. 2019 ASCCPRisk-Based Management Consensus Guidelines forabnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020
  5. Ronco G, Dillner J, Elfström KM et al. Efficacy ofHPV-based screening for prevention of invasivecervical cancer: follow-up of four Europeanrandomised controlled trials. Lancet. 2014
  6. Katki H, Schiffman M, Castle P et al. BenchmarkingCIN 3+ RISK as the basis for incorporating HPV andPap cotesting into cervical screening andmanagement guidelines. J Low Genit Tract Dis. 2013
  7. Gultekin M, Zayifoglu Karaca M, et al. Initial resultsof population based cervical cancer screeningprogram using HPV testing in one million Turkishwomen. Int J Cancer. 2018
  8. Turkish Cervical Cancer and Cervical CytologyResearch Group. Prevalence of cervical cytologicalabnormalities in Turkey. Int J Gynaecol Obstet. 2009
  9. Arslan E, Gokdagli F, Bozdag H, et al. AbnormalPap smear frequency and comparison of repeatcytological follow-up with colposcopy duringpatient management: the importance ofpathologist’s guidance in the management. NorthClin Istanb. 2018
  10. 74 10.Wang SS, Sherman ME, Hildesheim A et al.Cervical adenocarcinoma and squamous cellcarcinoma incidence trends among white womenand black women in the United States for 1976-2000. Cancer. 2004
  11. Boyraz G, Basaran D, Salman MC et al.Histological follow-up in patients with atypicalglandular cells on Pap smears. J Cytol. 2017
  12. Toyada S, Kawaguchi R, Kobayashi H.Clinicopathological Characteristics of AtypicalGlanduler Cells Determined by Cervical Cytology inJapan: Survey of Gynecologic Oncology DATA FromThe Obstetrical Gynecological Society of KinkiDistrict, Japan. Acta Cytol. 2019
  13. Kim SS, Suh DS, Kim KH, et al. Clinicopathologicalsignificance of atypical glandular cells on Pap smear.Obstet Gynecol Sci. 2013
  14. 76‑83. 14.Mood NI, Efte